摘要
目的:探讨注射用灯盏花素对糖尿病周围神经病变(DPN)患者神经功能和氧化应激的影响。方法:90例DPN患者随机按数字法分为观察组和对照组各45例。对照组采用甲钴胺片0.5 mg/次,3次/d。疗程12周。观察组在对照组基础上加用注射用灯盏花素50 mg,1次/d,2周为1个疗程,间隔2周后进行下一疗程,共3个疗程。记录治疗前后神经症状、体征评分,检测治疗前后正中神经、尺神经、腓总神经、胫前神经的运动传导速度(MNCV)和感觉传导速度(SNCV),检测血清总抗氧化能力(TAOC)、超氧化物歧化酶(SOD)、丙二醛(MDA)。结果:观察组总有效率91.11%,优于对照组的71.11%(P<0.05);治疗后两组神经症状、体征评分及总分均较治疗前显著下降,观察组评分低于对照组(P<0.01);治疗后两组正中神经、尺神经、腓总神经、胫前神经的MNCV均有明显改善,观察组的改善优于对照组(P<0.05或P<0.01);治疗后两组正中神经、尺神经、腓总神经、胫前神经的SNCV均有明显改善,观察组的改善优于对照组(P<0.01);治疗后观察组TAOC、SOD水平较治疗前升高,并高于对照组(P<0.05),MDA水平显著下降,并低于对照组(P<0.01)。结论:注射用灯盏花素能改善DPN患者神经症状、体征,改善神经运动神经传导速度和感觉传导速度,疗效显著,其作用机制可能与减轻氧化应激损伤有关。
Objective： Breviscapine injection To observe the influence on nerve function and oxidative stress of patients with diabetic peripheral neuropathy disease. Method： Ninety patients were randomly divided into observation group （n=45） and control group （n=45）.Patients in the control group were treated with conventional Western therapy. Patients in observation group were treated with mecobalamine tablets,0.5 mg/time,3 times/d,12 weeks as on cycle. Breviscapine injection was added to the patients in observation group,50 mg,1 times/d,2 weeks for one cycle,interval of two weeks after the next course of treatment. Recorded neurological symptoms and signs scores before and after treatment,detected conduction velocity （MNCV） and sensory conduction velocity （SNCV） of the median nerve,ulnar nerve,peroneal nerve,tibial nerve,and detected serum total antioxidant capacity （TAOC）,superoxide dismutase （SOD）,malondialdehyde （MDA） before and after the treatment. Result： The total efficacy of the observation group （91.11% ） was significantly better than the control group （71.11% ）（P〈0.05）. After treatment,neurological symptoms,signs score and total score were decreased significantly,and the score of observation group was lower than the control group（P〈0.01）. MNCV of median nerve,ulnar nerve,peroneal nerve,tibial nerve showed significant improvement,the improvement of the observation group was better than the control group （P〈0.05 or P〈0.01）;SNCV of median nerve,ulnar nerve,peroneal nerve,tibial nerve showed significant improvement,the improvement of the observation group was better than the control group （P〈0.01）;After treatment,TAOC,SOD levels of the observation group were raised and was higher than the control group （P〈0.05）,MDA levels were significantly decreased,and lower than the control group （P〈0.01）. Conclusion： Breviscapine injection can improve the patients with DPN on neurological symptoms and signs,and can improve nerve motor nerve conductio
出处
《中国实验方剂学杂志》
CAS
北大核心
2013年第23期274-277,共4页
Chinese Journal of Experimental Traditional Medical Formulae
基金
四川省中医药管理局项目(20101075Z-1)
